DUBLIN--(BUSINESS WIRE)--The "Asia Pacific DNA Sequencing Market 2021-2031 by Offering, Sequencing Type, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Asia Pacific DNA sequencing market will grow by 17.4% annually with a total addressable market cap of $75,903.7 million over 2022-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Instruments
• Consumables
• Sequencing Services

Based on Sequencing Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Sanger Sequencing
• Next Generation Sequencing
• Other Sequencing Types

By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Chain Termination Sequencing
• Pyrosequencing
• Sequencing by Ligation (SBL)
• Single-Molecule Real-Time Sequencing (SMRT)
• Nanopore Sequencing
• Other Technologies

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Biomarker Discovery
• Diagnostics
• Personalized Medicine
• Reproductive Health
• Forensics
• Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Academics and Research Organizations
• Pharmaceutical and Biotechnology Companies
• Hospitals & Clinics
• Other End Users

Selected Key Players:

• Agilent Technologies Inc.
• BGI Genomics Co., Ltd.
• Bio-Rad Laboratories Inc.
• Danaher Corporation (Integrated DNA Technologies Inc.)
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• Merck KGaA
• Pacific Biosciences of California Inc.
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Asia Pacific Market by Offering

4 Segmentation of Asia Pacific Market by Sequencing Type

5 Segmentation of Asia Pacific Market by Technology

6 Segmentation of Asia Pacific Market by Application

7 Segmentation of Asia Pacific Market by End User

8 Asia-Pacific Market 2021-2031 by Country

9 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/hqybjg

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900